<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0047">
 <label>47</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0047">
  <string-name>
   <surname>Minami</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Minami</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Miyamoto</surname>
   <given-names>T</given-names>
  </string-name>, et al. 
  <article-title>Phase I study of glasdegib (PF‐04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies</article-title>. 
  <source xml:lang="en">Cancer Sci.</source>
  <year>2017</year>;
  <volume>108</volume>:
  <fpage>1628</fpage>‐
  <lpage>1633</lpage>.
  <pub-id pub-id-type="pmid">28556364</pub-id>
 </mixed-citation>
</ref>
